Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer.

Xin, Xing; Wen, Ti; Gong, Li-Bao; Deng, Ming-Ming; Hou, Ke-Zuo; Xu, Lu; Shi, Sha; Qu, Xiu-Juan; Liu, Yun-Peng; Che, Xiao-Fang; Teng, Yue-E.

Afiliação

Xin X; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Wen T; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Gong LB; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Deng MM; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Hou KZ; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xu L; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Shi S; Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.
Qu XJ; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Liu YP; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Che XF; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Teng YE; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.